BioNTech SE (BNTX) Invested Capital (2018 - 2024)

BioNTech SE (BNTX) has 7 years of Invested Capital data on file, last reported at $17.4 million in Q4 2024.

• For the quarter ending Q4 2024, Invested Capital fell 58.28% year-over-year to $17.4 million; the trailing twelve-month figure through Sep 2025 stood at $17.4 million (down 58.28% YoY), and the FY2024 full-year result was $17.4 million, down 58.28% from the prior year.
• Invested Capital retreated to $17.4 million in Q4 2024, from $41.7 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.9 billion in Q4 2021 to a low of $6.2 million in Q4 2022.
• A 5-year average of $387.6 million and a median of $40.9 million in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital tumbled 99.67% in 2022 and jumped 570.79% in 2023, its largest moves.
• Tracing BNTX's Invested Capital over 5 years: stood at $323.1 million in 2020, then soared by 487.01% to $1.9 billion in 2021, then plunged by 99.67% to $6.2 million in 2022, then jumped by 570.79% to $41.7 million in 2023, then slumped by 58.28% to $17.4 million in 2024.
• Business Quant data shows BNTX's Invested Capital at $17.4 million in Q4 2024, $41.7 million in Q4 2023, and $40.1 million in Q1 2023.